These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 19125993)

  • 1. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
    Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
    Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
    Maitra A; Pingle RR; Menon PS; Naik V; Gokral JS; Meherji PK
    Int J Fertil Womens Med; 2001; 46(5):271-7. PubMed ID: 11720200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid and lipoprotein profile in women with polycystic ovary syndrome.
    Macut D; Panidis D; Glisić B; Spanos N; Petakov M; Bjekić J; Stanojlović O; Rousso D; Kourtis A; Bozić I; Damjanović S
    Can J Physiol Pharmacol; 2008 Apr; 86(4):199-204. PubMed ID: 18418429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome.
    Doi SA; Abbas JM; Parkinson L; Chakraborty J; Akanji AO
    Am J Clin Pathol; 2008 May; 129(5):802-10. PubMed ID: 18426742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) levels in girls with premature adrenarche.
    Andiran N; Yordam N
    J Paediatr Child Health; 2008 Mar; 44(3):138-42. PubMed ID: 18307419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
    ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?
    Rizzo M; Berneis K; Carmina E; Rini GB
    Am J Obstet Gynecol; 2008 Jan; 198(1):28.e1-5. PubMed ID: 18166299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.